FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s DiseaseMay 11, 2023 12:00:00 AMThe U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...